受强制性开放获取政策约束的文章 - Dimitar Maslarov了解详情
可在其他位置公开访问的文章：2 篇
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
DMOPEPDSG F. Stocchi, O. Rascol, R. A. Hauser, S. Huyck, A. Tzontcheva, R ...
Neurology, 2017
强制性开放获取政策： National Institute of Health and Medical Research, France, Parkinson's …
Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
E Trinka, R Rocamora, J Chaves, J Moreira, F Ikedo, P Soares‐da‐Silva, ...
Epilepsia 61 (10), 2129-2141, 2020
强制性开放获取政策： Austrian Science Fund
出版信息和资助信息由计算机程序自动确定